BioAtla raises $7.5M via PPAs and $15M SEPA; Yorkville gets 243,428 commitment shares

BioAtla, Inc.

PPAs for $7.5M face amount; net proceeds ~$7.13M at 95% of face; due in 12 months.
PPA conversion price is lower of 115% of prior VWAP or 95% of lowest 7-day VWAP, with floor at 20% of closing price.
SEPA allows BioAtla to sell up to $15M common stock to Yorkville over 36 months at 97% of lowest 3-day VWAP.
Yorkville received 243,428 commitment shares worth $300,000 as SEPA fee.
Company restricts other variable-rate transactions until PPA repaid; 19.99% Exchange Cap may limit total shares.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

BioAtla, Inc. entered into Standby Equity Purchase Agreement with YA II PN, Ltd. valued at Standby Equity Purchase Agreement (effective 2025-11-20).

Action: entry
Agreement: equity purchase
Counterparty: YA II PN, Ltd.
Value: Standby Equity Purchase Agreement
Effective: 2025-11-20

Exact text from the filing

Also on November 20, 2025 (the “Effective Date”), the Company entered into the Standby Equity Purchase Agreement (the “SEP

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

BioAtla, Inc. entered into Pre-Paid Advance Agreement with YA II PN, Ltd.; Anson Investments Master Fund LP; Anson East Master Fund LP valued at $7.5 million Pre-Paid Advance; gross proceeds of approx. $7.13 million (effective 2025-11-20).

Action: entry
Agreement: equity purchase
Counterparty: YA II PN, Ltd.; Anson Investments Master Fund LP; Anson East Master Fund LP
Value: $7.5 million Pre-Paid Advance; gross proceeds of approx. $7.13 million
Effective: 2025-11-20

Exact text from the filing

On November 20, 2025, BioAtla, Inc. (the “Company”) entered into Pre-Paid Advance Agreements (the “PPAs”) with each of YA II PN, Ltd., a Cayman Islands exempt limited partnership (“Yorkville”), Anson Investments Master Fund LP and Anson East Master Fund LP (collectively, the “Investors”).

View on SEC.gov

Browse all material agreements →

BioAtla, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-290474

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.